Patient Reported Outcome After Surgical Treatment of DDD in Scandinavia
Comparison of Baseline Characteristics and Patient Reported Outcome After Surgical Treatment of Degenerative Lumbar Disc Disease in Scandinavia
1 other identifier
observational
3,500
0 countries
N/A
Brief Summary
Purpose: The incidence of surgery for Degenerative lumbar Disc Disease (DDD). According to the national spine registries in Sweden, Norway and Denmark, there is a difference in surgical incidence between these countries. The cause for this difference is not known. It may reflect a difference in incidence of lumbar disc hernia, but with a similar socio-economic and ethnical background in these countries, it is more likely that the differences are due to varying surgical indications. Comparing indications for surgery, patient reported outcome and factors predictive for outcome after surgery for lumbar disc decease in these countries could provide information about optimal indications for surgery. Hypotheses: (i) there are no differences in patient-reported outcome after surgery between these countries, (ii) there are no differences in indications for surgery between these countries and (iii), factors that predict outcome are similar in these countries. Method of research: By using data from three Nordic national spine registers, investigators will compare baseline data, indications for surgery and patient reported outcome one year after surgery for lumbar disc decease. Register based studies have advantages such as large sample sizes, reflecting real life, but they also have limitations such as lower follow-up rates than clinical trials. A non-response analysis will be performed to take this into account.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 30, 2016
CompletedFirst Posted
Study publicly available on registry
December 2, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2019
CompletedJuly 30, 2024
July 1, 2024
8.1 years
November 30, 2016
July 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Oswestry disability index version 2.1 (from 0; no disability to 100; maximum disability)
Baseline and 1 year postoperative
Secondary Outcomes (4)
Numerical rating scale for leg pain (from 0; no pain to 10; maximum pain) . The numerical rating scale is used in Norway. The visual analogue scale (0-100) used in Sweden and Denmark will be converted to the numerical rating scale.
Baseline and 1 year postoperative
EQ-5D according to the British tariff (UK-TTO; from -0.59; worst possible health to 1; perfect health).
baseline and 1 year postoperative
Return to work rate
Baseline and 1 year postoperative
Additional surgery in the same segment of the lumbar spine
During 1 year
Study Arms (1)
Sweden, Denmark, Norway
Group: Degenerative lumbar disc disease patients treated in Sweden and included in the Swespine register Group: Degenerative lumbar disc disease patients treated in Norway and included in the NORspine register Group: Degenerative lumbar disc disease patients treated in Denmark and included in the DaneSpine register
Eligibility Criteria
Included are individuals treated surgically for DDD between the ages of 18 through 65 years. Surgery has been performed in Denmark, Norway or Sweden during 2011, 2012 or 2013
You may qualify if:
- All patients operated due to DDD in the Scandinavian countries during 2011, 2012 or 2013
You may not qualify if:
- No history of previous lumbar spine surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mikkel Ø Andersen, MD
Sygehus Lilleaelt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Nurse, Head of the national DaneSpine office
Study Record Dates
First Submitted
November 30, 2016
First Posted
December 2, 2016
Study Start
January 1, 2011
Primary Completion
January 31, 2019
Study Completion
January 31, 2019
Last Updated
July 30, 2024
Record last verified: 2024-07